SCHEMBL755569

SCHEMBL755569

NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1.[H+]

nearest known ligand 0.98

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 2/20 0.98
LMNA P02545 1/20 0.74
PMP22 Q01453 1/20 0.74
TP53 P04637 1/20 0.74
TSHR P16473 1/20 0.74
ALOX12 P18054 1/20 0.74
P2RY1 P47900 6/20 0.72
P2RY2 P41231 2/20 0.72
P2RX1 P51575 2/20 0.72
P2RX3 P56373 2/20 0.72
ALDH1A1 P00352 2/20 0.72
SRC P12931 1/20 0.72
P2RX4 Q99571 1/20 0.72
P2RX2 Q9UBL9 1/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
LDHA P00338 1/20 0.71
LDHB P07195 1/20 0.71
MACROD2 A1Z1Q3 1/20 0.68
SIRT6 Q8N6T7 1/20 0.68
MACROD1 Q9BQ69 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8188 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29740660 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29351291 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL1276381 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL8003782 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29548827 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29350404 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL20202727 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL8187 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL25792100 0.99 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114806965-A Probiotic agent for improving storage stability of strains and preparation method and application thereof 微康益生菌(苏州)股份有限公司 2022-07-29 CN disclosed
CN-107723314-B Method for improving hydrogen production of natural mixed bacteria source NADH (nicotinamide adenine dinucleotide) pathway 河南工程学院 2020-09-04 CN disclosed
CN-107723314-B Method for improving hydrogen production of natural mixed bacteria source NADH (nicotinamide adenine dinucleotide) pathway 河南工程学院 2020-09-04 CN disclosed
CN-107613849-A Systems and methods for injury assessment 乔治华盛顿大学 2018-01-19 CN disclosed
CN-107427213-A System and method for evaluation of contact quality 拉克斯凯瑟有限责任公司 2017-12-01 CN disclosed
CN-104066368-B Systems and methods for visualizing ablated tissue 乔治华盛顿大学 2017-02-22 CN disclosed
US-9322893-B2 Methods of distinguishing between glutamine formed by cataplerosis or proteolysis BIOCANT-ASSOCIAÇÃO DE TRANSFERÊNCIA DE TECNOLOGIA (PT) 2016-04-26 US disclosed
EP-2286238-B1 METHODS OF DISTINGUISHING BETWEEN GLUTAMINE FORMED BY CATAPLEROSIS OR PROTEOLYSIS BIOCANT ASSOCIACAO DE TRANSFERENCIA DE TECNOLOGIA (PT) 2012-03-21 EP disclosed
CN-101613671-B Hydrogen producing engineering bacteria and application thereof TSINGHUA UNIVERSITY (CN) 2011-12-28 CN disclosed
US-20110079093-A1 Methods of Distinguishing Between Glutamine Formed by Cataplerosis or Proteolysis BIOCANT (PT) 2011-04-07 US disclosed
EP-2286238-A1 METHODS OF DISTINGUISHING BETWEEN GLUTAMINE FORMED BY CATAPLEROSIS OR PROTEOLYSIS Biocant - Associação De Transferência De Tecnologia (PT) 2011-02-23 EP disclosed
WO-2009141619-A1 METHODS OF DISTINGUISHING BETWEEN GLUTAMINE FORMED BY CATAPLEROSIS OR PROTEOLYSIS Biocant - Associação De Transferência De Tecnologia (PT) 2009-11-26 WO disclosed